¹Ù·Î°¡±â ¸Þ´º
º»¹®³»¿ë ¹Ù·Î°¡±â

´ëÇÑÀÇÇÐȸ E-NEWSLETTER No.79 NOVEMBER 2017

ISSN 2287-9390 (Online)

´ëÇÑÀÇÇÐȸ(Korean Academy of Medical Sciences). The enhancement of medical specialties through education, research and training

Á¤¹ÐÀÇ·á°¡ ¿ä±¸ÇÏ´Â ¹ÙÀÌ¿À¹ðÅ©

Á¤¹ÐÀÇ·á°¡ ¿ä±¸ÇÏ´Â À¯ÀüÀÚ ¿¬±¸ °¡´ÉÇÏ·Á¸é ±¹³» ¹ÙÀÌ¿À¹ðÅ· ½Ã½ºÅÛ ±¸Ãà ÇÊ¿ä

  • ȨÀ¸·Î À̵¿
  • Àμâ
³² µµ Çö
¼º±Õ°üÀÇ´ë ½Å°æ¿Ü°úÇÐ
ÀÌ Áø ±¸
»ï¼º¼­¿ïº´¿ø ³­Ä¡¾Ï¿¬±¸»ç¾÷´Ü Ã¥ÀÓ¿¬±¸¿ø

Á¤¹Ð ÀÇ·á ÃÖÀûÈ­ Â÷¼¼´ë ¹ÙÀÌ¿À¹ðÅ·(Next-generation Biobanking) ½Ã½ºÅÛ

Àΰ£ »ý°ËÁ¶Á÷ ¹× Ç÷¾× µî ÀÎüÀ¯·¡¹°(Biospecimen)Àº ȯÀÚ Áß½ÉÀÇ Áúº´ ¿¬±¸¸¦ À§ÇØ ÇʼöÀûÀÎ Àç·áÀÌ´Ù. ±×·¯¹Ç·Î, ÀÌ·¯ÇÑ ÀÎüÀ¯·¡¹°À» °ü¸®ÇÏ°í º¸Á¸Çϱâ À§ÇÑ ¹ÙÀÌ¿À¹ðÅ© ¼³¸³ ¹× À¯Áö´Â ÃÖ±Ù Àӻ󿬱¸ÀÇ °¡Àå Áß¿äÇÑ ÅäÇÈ Áß Çϳª·Î ¶°¿À¸£°í ÀÖ´Ù. ÀÎüÀ¯·¡¹° º¸Á¸¿¡ ´ëÇÑ Çʿ伺ÀÌ ¿¬±¸Àڵ鰣¿¡ Áõ°¡ÇÒ ¼ö·Ï, ±× À¯·¡¹°ÀÇ ÁúÀû ¾çÀû °ü¸®ÀÇ Ã¼°è ±¸Ãà¿¡ ´ëÇÑ ¿ä±¸°¡ ¸¹¾ÆÁö°í ÀÖ°í, ÀÌ·¯ÇÑ ¿ä±¸µéÀ» ü°èÈ­ ÇÑ °ÍÀÌ ¼±ÁøÈ­µÈ ¹ÙÀÌ¿À¹ðÅ© ½Ã½ºÅÛÀÇ ÇÙ½ÉÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ÈçÈ÷ ¸¹Àº ÀÓ»ó ¿¬±¸ÀÚµéÀÌ ¹ÙÀÌ¿À¹ðÅ·(Biobanking) ½Ã½ºÅÛÀ» ¼¼Æ÷¹è¾ç, ºÐÀÚ»ý¹°ÇÐ ¿¬±¸½Ã¼³, µ¿¹°½ÇÇè½Ç µî°ú °°Àº ´Ù¸¥ ¿¬±¸ ÀÎÇÁ¶ó½ºÆ®·°ÃÄ(Infrastructure)¿Í ºñ½ÁÇÑ °³³äÀ¸·Î ÀνÄÇÏÁö¸¸, ¹ÙÀÌ¿À¹ðÅ©´Â À±¸®Àû, ¹ýÀû ±×¸®°í »çȸÀû À̽´µéÀ» Æ÷°ýÇÏ°í Àֱ⠶§¹®¿¡, ¼³¸³ ½ÃÁ¡ºÎÅÍ ´Ù¸¥ °³³äÀ¸·Î ÀνÄÇؾ߸¸ ÇÑ´Ù1,2.

Á¾¾ç ¿¬±¸¿¡¼­ Â÷¼¼´ë ¹ÙÀÌ¿À¹ðÅ· ½Ã½ºÅÛÀ̶õ ÀÎü »ý°Ë Á¶Á÷(¾×ü »ý°Ë ¹× Á¾¾ç Á¶Á÷ Æ÷ÇÔ)À» ȯÀÚÀÇ °¢±â ´Ù¸¥ ½ÃÁ¡(¿ø¹ß ¹× Àç¹ß)¿¡¼­ È®º¸ÇÏ°í, ´ÙÂ÷¿ø ÃÊ°í¼Ó(Multidimensional high-throughput) ºÐ¼®À» À§ÇÑ ÃÖÀûÈ­µÈ ÀÎüÀ¯·¡¹°ÀÇ °ü¸® ½Ã½ºÅÛÀ» ÀǹÌÇÑ´Ù 3,4. ÀÌ·¯ÇÑ ½Ãµµ´Â Á¾¾çÀÌ Ç×¾ÏÁ¦ ³»¼ºÀ» ȹµæÇØ°¡¸é¼­ Á¡Á¡ Ä¡·áºÒÀÀ »óÅ·ΠÁøÈ­ÇÏ´Â Çö»ó¿¡ ´ëÇÑ Ã¼°èÀûÀÎ ¿¬±¸ÀÇ Çʿ伺¿¡ ºñ·ÔÇÑ´Ù°í ÇÒ ¼ö ÀÖ´Ù. Â÷¼¼´ë ¹ÙÀÌ¿À¹ðÅ© ½Ã½ºÅÛÀ» È®¸³Çϱâ À§ÇÏ¿© ÇʼöÀûÀ¸·Î °í·ÁÇØ¾ß ÇÒ »çÇ×µéÀº ´ÙÀ½°ú °°´Ù.

ù ¹ø°, ÃÊ°í¼Ó À¯Àüü ¿¬±¸¸¦ À§ÇÑ Â÷¼¼´ë ½ÃÄö½Ì ÀÎÇÁ¶ó½ºÆ®·°ÃÄÀÇ ±¸ÃàÀÌ ÇÊ¿äÇÏ´Ù. The Cancer Genome Atlas (TCGA) ÇÁ·ÎÁ§Æ®ÀÇ ¼º°øÀûÀÎ ¼öÇà°ú ±× ºÐ¼® µ¥ÀÌÅÍ°¡ ÇöÀç Á¾¾ç »ý¹°ÇÐÀÇ ÀÌÇØ ¹× ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼ ½Ã½ºÅÛÀÇ Ã¼°è¸¦ ÇÑÂ÷¿ø ¾÷±×·¹ÀÌµå ½ÃŲ »ç·Ê´Â ü°èÈ­µÈ ÀÎüÀ¯·¡¹° °ü¸®¿Í Â÷¼¼´ë ½ÃÄö½Ì ¹× ºÐ¼® ½Ã½ºÅÛÀÇ Çù·ÂÀû ¿¬±¸°¡ ¾ó¸¶³ª Å« ¹ÝÇâÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´ÂÁö Àß º¸¿©ÁÖ´Â ¿¹½Ã¶ó ÇÒ ¼ö ÀÖ´Ù5,6.

µÎ ¹ø°, ÀÎüÀ¯·¡¹° ¼öÁý ¹× °ü¸® ü°èÀÇ ¾çÀû ÁúÀû Çâ»óÀÌ Àý½ÇÈ÷ ¿ä±¸µÈ´Ù. ÀüÅëÀûÀ¸·Î, ¹ÙÀÌ¿À¹ðÅ©¿¡¼­ ¼öÁýµÇ´Â »ùÇõéÀº Áø´Ü ¸ñÀûÀ» À§ÇÑ º´¸®°ú ÀÇ·Ú Á¶Á÷À» Á¦¿ÜÇÏ°í ³²Àº ºÎºÐµéÀÌ º¸°üµÇ¾î¿Ô´Ù. ±×·¯³ª, Ç×¾ÏÄ¡·á¿¡ ÀÇÇÑ Á¾¾ç ÁøÈ­, Á¾¾ç³» ´Ù¾ç¼º ¹× Á¾¾ç-Á¤»óÁ¶Á÷°£ »ó°ü°ü°è µîÀ» ºÐ¼®Çϱâ À§ÇÏ¿© ¹Ì¸® µðÀÚÀεÈ(Pre-designed) ÀÎüÀ¯·¡¹° ¼öÁýÀÌ ÇÊ¿äÇÏ´Ù. ¸¶Âù°¡Áö·Î, ¼öÁýµÈ »ùÇÃÀÇ ±â·Ï(Documentation) ¹× ÁúÀû °ü¸®(Quality management) ü°è¸¦ ±¸ÃàÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù. µû¶ó¼­ °ËÁõµÈ Ç¥ÁØÀÛ¾÷Áöħ(SOP) ½Ã½ºÅÛ ±¸Ãà°ú »ùÇà ¾î³ëÅ×À̼Ç(ÁÖ¼®: annotation) ü°è¸¦ È®¸³ÇÏ´Â °ÍÀÌ ÇʼöÀûÀÌ´Ù7.

¼¼ ¹ø°, Á¤º¸ °ü¸® ½Ã½ºÅÛ(Information technology management system)ÀÇ ±¸ÃàÀÌ ÇÊ¿äÇÏ´Ù7. Â÷¼¼´ë ¹ÙÀÌ¿À¹ðÅ· ½Ã½ºÅÛÀÇ ÇÙ½ÉÀû ¿ä¼Ò´Â Â÷¼¼´ë ½ÃÄö½ÌÀ» ±â¹ÝÀ¸·Î ÇÑ »ý¸íÁ¤º¸ÇÐ(Bioinformatics) µ¥ÀÌÅÍÀÌ´Ù. ±×·¯³ª, À¯Àüü µ¥ÀÌÅÍ¿¡ ÀÓ»óÀû Àǹ̸¦ ºÎ¿©ÇÏ´Â °ÍÀº º´¸®Á¤º¸, ȯÀÚÁ¤º¸, Ä¡·áÁ¤º¸, °¡Á··Â, ºÐÀÚÈ­ÇÐÀû Áø´ÜÁ¤º¸ µîÀÌ ÅëÇÕÈ­(Integrated)µÈ Á¤º¸ µ¥ÀÌÅͺ£À̽ºÀÌ´Ù. ÃÖ±Ù ÀÌ·¯ÇÑ Á¤º¸µéÀ» ¼öÁý(storing)ÇÏ°í ÃßÀû(tracking)ÇÏ¿© Àӻ󿬱¸ È°¿ë¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Â ¹ÙÀÌ¿À¹ðÅ© Á¤º¸°ü¸® ½Ã½ºÅÛ(Biobank Information Management System: BIMS) °³¹ßÀÌ ¹ÙÀÌ¿À¹ðÅ© »ê¾÷ÀÇ ÇÙ½É ÅäÇÈÀ¸·Î ¶°¿À¸£°í ÀÖ´Â °ÍÀº ¸Å¿ì ´ç¿¬ÇÑ ÀÏÀÌ´Ù.

¸¶Áö¸·À¸·Î ȯÀÚµ¿ÀDZâ¹ÝÀÇ ¿¬±¸À±¸® ½Ã½ºÅÛÀÇ È®¸³ÀÌ ÇÊ¿äÇÏ´Ù. ȯÀÚ¿¡°Ô °Ëü ¼öÁý¿¡ ´ëÇÑ Á¦¹Ý Á¤º¸¸¦ ¾Ë·ÁÁÖ°í, ±×¿¡ ´ëÇØ ¼­¸é µ¿ÀǸ¦ ¾ò´Â °ÍÀº ¹ÙÀÌ¿À¹ðÅ© ¼­·ù ½Ã½ºÅÛ Áß °¡Àå Áß¿äÇÏ´Ù. ±âÁõÀÚ ¶Ç´Â ¿¬±¸ µ¿ÀǼ­¿¡´Â ¿¬±¸ÀÇ ¸ñÀû, »ç¿ë±âÇÑ, ¿¹»óµÇ´Â °á°ú ¹× ±âÁõÀÚÀÇ ±Ç¸® µî¿¡ ´ëÇØ »ó¼¼È÷ ±â·ÏµÇ¾î¾ß ÇÑ´Ù, ±×·¯³ª, °°Àº ȯÀÚÀÇ »ùÇÃÀÌ ¿©·¯ ´Ù¸¥ ¿¬±¸¿¡ »ç¿ëµÇ´Â °æ¿ì °¢±â ´Ù¸¥ µ¿ÀǼ­¿¡ ¼­¸íÀ» ¹Þ´Â °ÍÀº ¸Å¿ì ¾î·Æ±â ¶§¹®¿¡, °¡´ÉÇÑ ¸ðµç ¿¬±¸µé¿¡ ´ëÇØ ¼³¸íÇÑ Æ÷°ýÀûÀÎ µ¿ÀǼ­(General consent)¸¦ ÀÛ¼ºÇÏ¿©, IRB(Institution Review Board)ÀÇ ½ÉÀǸ¦ °ÅÃÄ ½ÂÀεǸé Æ÷°ýµ¿ÀǼ­·Î ´ëüÇÒ ¼ö ÀÖ´Ù. ȯÀÚ´Â °³ÀÎÁ¤º¸¸¦ º¸È£¹ÞÀ» ±Ç¸®°¡ Àֱ⠶§¹®¿¡, ȯÀÚ¿¡ ´ëÇØ ½Äº°ÇÒ ¼ö ÀÖ´Â Á¤º¸´Â À͸íÈ­(De-identify)ÇÏ¿© ¿¬±¸ÀÚ¿¡°Ô Á¦°øµÇ¾î¾ß ÇÑ´Ù.

»ï¼º¼­¿ïº´¿ø Â÷¼¼´ë ¹ÙÀÌ¿À¹ðÅ© ½Ã½ºÅÛÀ» ÀÌ¿ëÇÑ ¼º°øÀû Àӻ󿬱¸ÀÇ »ç·Ê¿Í ¹Ì·¡ ¹ÙÀÌ¿À ¹ðÅ©

»ï¼º¼­¿ïº´¿øÀº ¾Æ¹ÙŸ½Ã½ºÅÛ°ú Á¢¸ñÇÑ È¯ÀÚÀ¯·¡¹° °ü¸® ½Ã½ºÅÛÀ» ±¸ÃàÇÏ¿´°í, °Ëü ¼öÁý, º¸°ü, °ü¸®¿¡ ´ëÇÑ Ç¥ÁØÀÛ¾÷ÁöħÀ» È®¸³ÇÏ¿´´Ù. À̸¦ ¹ÙÅÁÀ¸·Î ±³¸ð¼¼Æ÷Á¾ ¿ø¹ß-Àç¹ß ½Ö(Initial-Recurrent pair) Á¶Á÷ ¹× Ç÷¾×À» ¼öÁýÇÏ¿´°í »ï¼ºÀ¯Àüü¿¬±¸¼Ò¿Í Çù·ÂÀ¸·Î °¢ »ùÇõ鿡 ´ëÇÑ Â÷¼¼´ë ½ÃÄö½Ì ±â¹Ý À¯ÀüÀÚ º¯ÀÌ ¿°±â¼­¿­ ¹× Àü»çü ºÐ¼®À» ¼öÇàÇÏ¿´´Ù. À̸¦ ¹ÙÅÁÀ¸·Î 22½ÖÀÇ ÀǷ῵»óÇÐÀû Àç¹ß ¾ç»ó¿¡ µû¸¥ ÁøÈ­¸ðµ¨À» È®¸³ÇÏ¿© ¼¼°èÀûÀÎ ÀÇÇÐ ÇмúÁöÀÎ Cancer Cell¿¡ 2015³â Ãâ°£ÇÏ¿´°í8, ¹Ì±¹ ÄÝ·Òºñ¾Æ ´ëÇÐ (Columbia University)°ú Çù·Â¿¬±¸¸¦ ÅëÇØ ¾à 110½ÖÀÇ ¿ø¹ß-Àç¹ß ½Ö º¯ÀÌ ºÐ¼®À» ÅëÇÑ Ç×¾ÏÄ¡·á¿¡ µû¸¥ À¯Àüü º¯ÀÌ ¾ç»óÀ» ºÐ¼®ÇÏ¿© ¼¼°èÀûÀÎ ÇмúÁöÀÎ Nature Genetics¿¡ 2016³â Ãâ°£ÇÏ¿´´Ù9. À̴ ü°èÈ­µÈ ȯÀÚÀ¯·¡¹° ¼öÁý°ú ¾î³ëÅ×À̼Ç, ÀÓ»ó ¹× ÀǷ῵»ó µ¥ÀÌÅÍ¿Í Á¢¸ñµÈ ¹ÙÀÌ¿À¹ðÅ© Á¤º¸°ü¸® ½Ã½ºÅÛÀÌ ¾çÁúÀÇ Àӻ󿬱¸¿¡ ¾ó¸¶³ª Áß¿äÇÑ°¡¸¦ Àß º¸¿©ÁØ »ç·Ê¶ó°í ÇÒ ¼ö ÀÖ´Ù. »ï¼º¼­¿ïº´¿ø¿¡¼­´Â º¸°Çº¹ÁöºÎ Áö¿øÀ» ¹Þ´Â ¼±µµÇü ³­Ä¡¾Ï¿¬±¸ »ç¾÷´Ü¿¡¼­ ¼ö¼úÈÄ È¯ÀÚÀÇ Á¾¾çÁ¶Á÷À» ÀÏÂ÷¹è¾çÇØ ¾à¹° ½ºÅ©¸®´×À» ÇÏ¿© Ç¥Àû ¾à¹°À» ¼±º°ÇÏ°í, ´Ù¾çÇÑ È¯ÀÚÀÇ À¯Àüü ¹× ¾à¹° ¹ÝÀÀ°á°ú¸¦ ¹Ý¿µÇÑ À¯ÀüÀÚ ºòµ¥ÀÌÅ͸¦ ±¸ÃàÇØ Á¤¹ÐÀǷḦ Áö¿øÇÏ°í ÀÖ´Ù. À¯Àüü¿Í ¾à¹° Áöµµ¸¦ ÀÌ¿ëÇØ È¯ÀÚÀÇ Æ¯ÀÌÇÑ ¹ß¾ÏÀÎÀÚ, Àç¹ß, Ç×¾Ï ³»¼º µî°ú °ü·ÃµÈ Á¤º¸¸¦ Á¾ÇÕÇÏ°í µ¿°áµÈ Á¾¾ç¼¼Æ÷¸¦ ´Ù½Ã ¹è¾çÇÏ°í µ¿¹°¸ðµ¨À» ¸¸µé¾î ºÒÀÀ¼º Àç¹ß¾ÏÄ¡·á¿¡ ÀÀ¿ëÇÏ°í, Çѱ¹Çü µðÁöÅÐ ¾à¹° °³¹ß¿¡ ÀÌ¿ëÇÔÀ¸·Î½á Á¤¹ÐÀÇ·áÀÇ ±Û·Î¹ú ¸®´õ½± È®º¸¿Í ¹ÙÀÌ¿À»ê¾÷À» Áö¿øÀ» Áö¿øÇÏ°í ÀÖ´Ù.

°á·Ð

Â÷¼¼´ë½ÃÄö½Ì ±â¼úÀÇ ´ëÁßÈ­¿Í ¸Â¹°·Á ´ë±Ô¸ð ÃÊ°í¼Ó À¯Àüü ½ºÅ©¸®´×À» ÅëÇÑ Á¤¹ÐÀÇ·á Ç÷§Æû ±¸ÃàÀÌ ³­Ä¡¾Ï Ä¡·á¹ý °³¹ßÀÇ °¡Àå Áß¿äÇÑ À̽´·Î ¶°¿À¸£°í ÀÖ´Ù. ±×·¯³ª, ÀÌ·¯ÇÑ Á¤¹ÐÀÇ·á ¿¬±¸¸¦ ¼º°øÀûÀ¸·Î ¼öÇàÇϱâ À§Çؼ­´Â ¾çÁúÀÇ ÀÎüÀ¯·¡¹° ¼öÁý ¹× ÅëÇÕ µ¥ÀÌÅͺ£À̽º °ü¸® ü°è¸¦ ±â¹ÝÀ¸·Î ÇÑ Â÷¼¼´ë ¹ÙÀÌ¿À¹ðÅ· ½Ã½ºÅÛÀÇ È®¸³ÀÌ ¼±ÇàµÇ¾î¾ß ÇÑ´Ù. º» ±â°í¸¦ ÅëÇÏ¿©, °¢ º´¿øÀÇ ¹ÙÀÌ¿À¹ðÅ© ÀÎÇÁ¶ó½ºÆ®·°ÃÄ ±¸Ãà »ç¾÷¿¡¼­ °í·ÁÇØ¾ß ÇÒ Á¡µéÀ» Á¡°ËÇغ¸°í ¿ì¸®³ª¶óÀÇ Àü¹ÝÀûÀΠȯÀÚÀ¯·¡¹° ±â¹Ý Á¤¹ÐÀÇ·á ¿¬±¸ÀÇ ÁúÀû, ¾çÀû Çâ»óÀÌ ÀÌ·ç¾îÁö±æ Èñ¸ÁÇϸ鼭 ±ÛÀ» ¸Î´Â´Ù.

  • 1. Watson, P.H. et al. A framework for biobank sustainability. Biopreserv Biobank 12, 60-8 (2014).
  • 2. Helgesson, G., Dillner, J., Carlson, J., Bartram, C.R. & Hansson, M.G. Ethical framework for previously collected biobank samples. Nat Biotechnol 25, 973-6 (2007).
  • 3. Basik, M. et al. Biopsies: next-generation biospecimens for tailoring therapy. Nat Rev Clin Oncol 10, 437-50 (2013).
  • 4. Esgueva, R. et al. Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium. Diagn Mol Pathol 21, 61-8 (2012).
  • 5. From TCGA to treatment. Cancer Discov 2, 1068 (2012).
  • 6. Cline, M.S. et al. Exploring TCGA Pan-Cancer data at the UCSC Cancer Genomics Browser. Sci Rep 3, 2652 (2013).
  • 7. Watson, R.W., Kay, E.W. & Smith, D. Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research. Nat Rev Cancer 10, 646-51 (2010).
  • 8. Kim, J. et al. Spatiotemporal Evolution of the Primary Glioblastoma Genome. Cancer Cell 28, 318-28 (2015).
  • 9. Wang, J. et al. Clonal evolution of glioblastoma under therapy. Nat Genet 48, 768-76 (2016).

ÃÖ»ó´ÜÀ¸·Î À̵¿